Myelopreservation with Trilaciclib in Patients Receiving...

  • Main
  • 2020 / 10
  • Myelopreservation with Trilaciclib in Patients Receiving...

Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study

Hart, Lowell L., Ferrarotto, Renata, Andric, Zoran G., Beck, J. Thaddeus, Subramanian, Janakiraman, Radosavljevic, Davorin Z., Zaric, Bojan, Hanna, Wahid T., Aljumaily, Raid, Owonikoko, Taofeek K., Ve
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Advances in Therapy
DOI:
10.1007/s12325-020-01538-0
Date:
October, 2020
File:
PDF, 530 KB
2020
Conversion to is in progress
Conversion to is failed